FDA Submissions
Embark on your clinical journey with confidence through our specialised services tailored for the FDA. From crafting robust Investigational New Drug (IND) applications to navigating the intricacies of New Drug Applications (NDA) and Abbreviated New Drug Applications (ANDA), we offer a spectrum of services to streamline your path through the FDA.
Our expertise extends to Biologics License Applications (BLA) and strategic FDA meeting preparations, ensuring a proactive and efficient approach.
Trusted by top-tier teams worldwide
Investigational New Drug (IND) Applications:
- Preparation and submission of IND packages including nonclinical and clinical data
- Crafting pre-IND meeting briefing packages
New Drug Applications (NDA) and Abbreviated New Drug Applications (ANDA):
- Support for NDA and ANDA submissions including CMC, nonclinical and clinical modules
- Assistance with Complete Response Letters (CRL) and response packages
Biologics License Applications (BLA):
- Strategic guidance for BLA preparation
- Support with comparability studies and accelerated approval pathways
FDA Meeting Preparation:
- Coordination of pre-submission meetings
- Creation of briefing documents and meeting packages
FAQs
We aim to make the process as simple to understand as possible and are always on hand to answer any questions you might have.
Here are some of the questions we get asked most often.
Our team has extensive experience in Advanced Therapy Medicinal Product (ATMP) clinical development and is well-versed in how to deliver compliance throughout the development process. Get in touch with us for further information.
Featured case studies
510(k) Submission
510(k) Submission Introduction Radiographic Dental Imagery Device – Class IIb Our client are a leading manufacturer of radiographic dental imaging systems, based in Europe. Following European success, our client set their sights on the US market. Standards & Tools FDA 21 CFR Part 820 GDPR Word Excel, Powerpoint Scope of work Review of documentation for…
Regulatory Strategy IVDR / FDA
Regulatory Strategy IVDR / FDA Introduction Deciphex Deciphex is a digital pathology workflow and integrated AI platform for research pathology, CROs and pharmaceutical companies for handling high volume drug safety pathology studies. They provide a complete GLP-compliant workflow with integrated AI screening capabilities. Standards & Tools EU-IVDR 2017-746 ISO 13485 ISO 14971 IEC 62366 GDPR…
Breakthrough Program
Breakthrough Program Introduction IVD manufacturer The company is a highly innovative IVD manufacturer start-up. Their device is CE marked and the client was looking to obtain FDA approval for sale on the US market. Apotech Consultants One consultant worked part-time on the project. The main focus was to design the rationale to be eligible for…